drugset / Trial / NCT03621046
Use of Low-dose Zolpidem in Parkinson's Disease
Phase 2
Completed
28 enrolled
Aston University
University Hospital Birmingham NHS Foundation Trust · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the motor and cognitive benefits of low-dose zolpidem in Parkinson's.
Timeline
- Start
- 2018-08-20
- Primary completion
- 2019-12-31
- Completion
- 2020-01-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zolpidem | Small molecule | 5 mg | Oral |